Mary Philip

Also affiliated with Vanderbilt University Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study”.

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00170-8

N/A

1.6DataRank · unranked

59 citations

Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren +15 more

Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1− Dysfunctional State

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0939

N/A

0.406DataRank · unranked

14 citations

Megan M. Erwin, Michael Rudloff, Natalie R. Favret, Carlos R. Detrés Román, Minna K.I. Apostolova +5 more

Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009129

N/A

0.104DataRank · unranked

1 citations

Megan M. Erwin, Michael W Rudloff, Frank Revetta, Kristen A. Murray, Natalie R. Favret +5 more

Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells

The Journal of Immunology(2023)10.4049/jimmunol.2200715

N/A

0DataRank · unranked

26 citations

Xiang Ye, Channing Chi, Emilie L. Fisher, Melissa M. Wolf, Gabriel A. Needle +11 more

Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.26.582064

N/A

0DataRank · unranked

0 citations

Michael W Rudloff, Frank Revetta, Natalie R. Favret, Kristen A. Murray, Jessica J. Roetman +4 more

MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.28.679049

N/A

0DataRank · unranked

0 citations

Megan M. Erwin, Natalie R. Favret, Claudia N. McDavid, Jessica J. Roetman, Zachary D. Ewell +6 more

TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion

The Journal of Experimental Medicine(2021)10.1084/jem.20201966

N/A

0DataRank · unranked

155 citations

Paul Zumbo, Gabriel Espinosa-Carrasco, Laura Menocal, Friederike Dündar, Sandra E. Carson +17 more

Pre-division TCF1 drop determines long-term CD8 T cell fates

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.06.680655

N/A

0DataRank · unranked

0 citations

Maider Astorkia, Melissa M. Wolf, Michael Rudloff, Claudia N. McDavid, Megan M. Erwin +10 more

Epigenetic encoding of T cell dysfunction is enacted within hours of tumor antigen encounter prior to cell division

Research Square(2022)10.21203/rs.3.rs-1927273/v1

N/A

0DataRank · unranked

0 citations

Michael Rudloff, Paul Zumbo, Natalie R. Favret, Jessica J. Roetman, Carlos Detres Roman +5 more

Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division

Nature Immunology(2023)10.1038/s41590-023-01578-y

N/A

0DataRank · unranked

132 citations

Paul Zumbo, Natalie R. Favret, Jessica J. Roetman, Carlos R. Detrés Román, Megan M. Erwin +6 more